InsiderTrades.com logo

SCTX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $56,291,746.20
Insider Selling (Last 12 Months): $0.00

Scribe Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Scribe Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Scribe Therapeutics Share Price & Price History

Current Price: $26.00
Price Change: ▲ Price Increase of +0.59 (2.32%)
As of 08/7/2026 04:00 PM ET

This chart shows the closing price history over time for SCTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Scribe Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/28/2026Behzad AghazadehDirectorBuy7,905$18.25$144,266.253,088,888View SEC Filing Icon  
7/27/2026Bio Fund Ii L.P. AhMajor ShareholderBuy333,333$15.00$4,999,995.002,385,075View SEC Filing Icon  
7/27/2026Carl L. GordonDirectorBuy1,000,000$15.00$15,000,000.001,348,825View SEC Filing Icon  
7/24/2026Behzad AghazadehDirectorBuy2,383,333$15.15$36,107,494.953,080,983View SEC Filing Icon  
7/23/2026David ParrotCFOBuy2,666$15.00$39,990.001,333View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Scribe Therapeutics (NASDAQ:SCTX)

Scribe Therapeutics logo
Scribe Therapeutics Inc. is a clinical-stage biotechnology company engineering CRISPR-based technologies into purpose-built in vivo genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent diseases, starting with cardiometabolic disease. Scribe Therapeutics Inc. is based in ALAMEDA, Calif.
Read More on Scribe Therapeutics

Today's Range

Now: $26.00
Low: $24.08
High: $26.50

50 Day Range

MA: N/A

52 Week Range

Now: $26.00
Low: $17.31
High: $26.50

Volume

120,169 shs

Average Volume

312,184 shs

Market Capitalization

$457.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Scribe Therapeutics?

Scribe Therapeutics' top insider investors include:
  1. Behzad Aghazadeh (Director)
  2. Bio Fund Ii LP Ah (Major Shareholder)
  3. Carl L Gordon (Director)
  4. David Parrot (CFO)
Learn More about top insider investors at Scribe Therapeutics.

Scribe Therapeutics Active Insiders

David Parrot
CFO
1 recent trades
Behzad Aghazadeh
Behzad Aghazadeh
Director
2 recent trades
Carl L Gordon
Carl L Gordon
Director
1 recent trades